Medicare Enrolled
Dr. Hitesh Patel, M.D.
Hematology · Clearwater, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Patel
Dr. Hitesh Patel is a hematology in Clearwater, FL, with 20 years in practice. Based on federal Medicare data, Dr. Patel performed 162,506 Medicare services across 2,962 unique beneficiaries.
Between the years covered by Open Payments, Dr. Patel received a total of $14,614 from 99 pharmaceutical and/or device companies across 698 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Patel is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 31% volume in FL$ $14,614 industry payments
Medicare Practice Summary
Medicare Utilization ↗162,506
Medicare services
Top 31% in FL for hematology
2,962
Unique beneficiaries
$3
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~8,125 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 79,050 | $0 | $4 |
| Filgrastim injection (Zarxio) for white blood cells | 42,420 | $0 | $2 |
| Epoetin alfa injection (Procrit) for anemia | 13,980 | $6 | $23 |
| Anti-nausea injection (aprepitant) | 7,800 | $1 | $5 |
| Denosumab injection (Prolia/Xgeva) | 6,540 | $18 | $51 |
| Complete blood count (CBC) with differential | 2,158 | $8 | $29 |
| Dexamethasone injection (steroid) | 1,998 | $0 | $3 |
| Blood draw (venipuncture) | 1,531 | $8 | $9 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,270 | $1 | $28 |
| Drug injection, under skin or into muscle | 806 | $10 | $69 |
| Office visit, established patient (30-39 min) | 751 | $96 | $339 |
| Anti-nausea injection (ondansetron/Zofran) | 632 | $0 | $9 |
| Office visit, established patient (20-29 min) | 567 | $65 | $239 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 450 | $22 | $84 |
| Administration of chemotherapy into vein, 1 hour or less | 441 | $97 | $378 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 318 | $47 | $189 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 198 | $15 | $56 |
| Injection of additional new drug or substance into vein | 187 | $12 | $61 |
| Infusion into a vein for hydration, each additional hour | 135 | $10 | $42 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 124 | $54 | $206 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 123 | $26 | $89 |
| Administration of additional new drug or substance into vein, 1 hour or less | 121 | $48 | $178 |
| Injection, diphenhydramine hcl, up to 50 mg | 121 | $1 | $3 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 102 | $17 | $59 |
| Injection of drug or substance into vein | 92 | $27 | $156 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 89 | $3 | $11 |
| Administration of chemotherapy into vein, each additional hour | 86 | $22 | $79 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 83 | $1 | $6 |
| Infusion, normal saline solution , 1000 cc | 68 | $2 | $7 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 66 | $134 | $562 |
| New patient office visit (45-59 min) | 47 | $125 | $453 |
| New patient office visit (30-44 min) | 35 | $80 | $298 |
| Automated urinalysis | 34 | $2 | $8 |
| Office visit, established patient, complex (40-54 min) | 31 | $138 | $474 |
| Infusion into a vein for hydration, 31-60 minutes | 19 | $25 | $156 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 17 | $1 | $7 |
| Red blood count, automated test | 16 | $4 | $10 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
49.4% high complexity
47.3% medium
3.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$14,614
Total received (2018-2024)
Avg $2,088/year across 7 years
Top 34% in FL for hematology
99
Companies
698
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,475 (85.4%)
Other
Charitable contributions, space rental, and other categories
$1,284 (8.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$855 (5.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$4,138
2023$1,981
2022$1,784
2021$1,911
2020$1,570
2019$1,652
2018$1,578
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,828
AstraZeneca Pharmaceuticals LP
$895
PFIZER INC.
$721
Janssen Biotech, Inc.
$609
GENZYME CORPORATION
$602
Lilly USA, LLC
$493
E.R. Squibb & Sons, L.L.C.
$490
Seagen Inc.
$465
Merck Sharp & Dohme Corporation
$455
Celgene Corporation
$440
Daiichi Sankyo Inc.
$432
Genentech USA, Inc.
$420
Amgen Inc.
$361
Incyte Corporation
$324
Gilead Sciences, Inc.
$297
Astellas Pharma US Inc
$276
Bayer HealthCare Pharmaceuticals Inc.
$253
Eisai Inc.
$244
Takeda Pharmaceuticals U.S.A., Inc.
$243
GlaxoSmithKline, LLC.
$216
Merck Sharp & Dohme LLC
$201
Exelixis Inc.
$189
ABBVIE INC.
$175
Regeneron Healthcare Solutions, Inc.
$170
CSL Behring
$156
TerSera Therapeutics LLC
$154
EMD Serono, Inc.
$146
Kite Pharma, Inc.
$131
TESARO, Inc.
$126
BeiGene USA, Inc.
$125
Ipsen Biopharmaceuticals, Inc
$120
SANOFI-AVENTIS U.S. LLC
$112
Janssen Pharmaceuticals, Inc
$107
Genmab U.S., Inc.
$93
Boehringer Ingelheim Pharmaceuticals, Inc.
$87
PUMA BIOTECHNOLOGY, INC.
$84
AbbVie, Inc.
$80
Agios Pharmaceuticals, Inc.
$77
Pharmacosmos Therapeutics Inc.
$76
Karyopharm Therapeutics Inc.
$76
Foundation Medicine, Inc.
$72
Kyowa Kirin, Inc.
$71
AMAG Pharmaceuticals, Inc.
$67
Stemline Therapeutics Inc.
$67
EISAI INC.
$65
Pharmacyclics LLC, an AbbVie Company
$64
SOBI, INC
$64
GE HEALTHCARE
$62
Pharmacyclics LLC, An AbbVie Company
$61
Sumitomo Pharma America, Inc.
$57
ARRAY BIOPHARMA INC
$55
Myovant Sciences Inc.
$53
Dendreon Pharmaceuticals LLC
$52
Deciphera Pharmaceuticals Inc.
$49
G1 Therapeutics, Inc.
$46
Dova Pharmaceuticals
$45
Lexicon Pharmaceuticals, Inc.
$45
Rigel Pharmaceuticals, Inc.
$44
Array BioPharma Inc.
$43
PharmaEssentia USA Corporation
$42
Tempus AI, Inc
$41
Blueprint Medicines Corporation
$39
AbbVie Inc.
$38
MorphoSys, US Inc.
$36
Shire North American Group Inc
$36
Epizyme, Inc.,
$36
Taiho Oncology, Inc.
$33
Aveo Pharmaceuticals, Inc.
$32
MEDIVATION FIELD SOLUTIONS LLC
$32
ADC Therapeutics America, Inc.
$32
Alexion Pharmaceuticals, Inc.
$31
AVEO Pharmaceuticals, Inc.
$31
JAZZ PHARMACEUTICALS INC.
$30
Sun Pharmaceutical Industries Inc.
$30
SpringWorks Therapeutics, Inc.
$28
Seattle Genetics, Inc.
$27
Sirtex Medical Inc
$26
Clovis Oncology, Inc.
$26
Myriad Genetic Laboratories, Inc.
$24
Alnylam Pharmaceuticals Inc.
$23
Bayer Healthcare Pharmaceuticals Inc.
$22
TG THERAPEUTICS, INC.
$21
Puma Biotechnology, Inc.
$20
INSYS Therapeutics Inc
$18
Mirati Therapeutics, Inc.
$18
TAIHO ONCOLOGY, INC.
$18
CTI BioPharma Corp.
$17
Immunomedics, Inc.
$16
Jazz Pharmaceuticals Inc.
$16
SERVIER PHARMACEUTICALS LLC
$16
Adaptive Biotechnologies Corporation
$16
Acceleron Pharma, Inc.
$15
Verity Pharmaceuticals Inc.
$15
Servier Pharmaceuticals LLC
$15
Acrotech Biopharma LLC
$14
Verastem, Inc.
$14
SHIELD THERAPEUTICS INC
$14
Sobi, Inc
$12
Aurobindo Pharma USA, Inc.
$12
Top 3 companies account for 23.6% of total payments
Associated products mentioned in payments ›
ACCRUFER · ADCETRIS · AFINITOR · ALUNBRIG · AYVAKIT · Abraxane · Afstyla · Alecensa · Aliqopa · Avastin · BESREMI · BLENREP · BOSULIF · BRACANALYSIS CDX · BRAFTOVI · BRUKINSA · Bavencio · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CERDELGA · CEREZYME · COSELA · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DOPTELET · Doptelet · ELITEK · ELREXFIO · EMEND · ENHERTU · ENJAYMO · ERBITUX · ERLEADA · Enhertu · Epkinly · Erleada · FASENRA · FASLODEX · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · GAZYVA · GILOTRIF · GIVLAARI · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · Idelvion · Imbruvica · JADENU · JAKAFI · JEMPERLI · JEVTANA · Jivi · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kcentra · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MARQIBO · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · NERLYNX · NINLARO · Neulasta · Nexavar · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONUREG · OPDIVO · ORGOVYX · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POLIVY · POTELIGEO · PROMACTA · PROVENGE · PYRUKYND · Padcev · Perjeta · Phesgo · Pomalyst · QINLOCK · REBLOZYL · RYBREVANT · Reblozyl · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SUTENT · SYNDROS · Stivarga · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Trelstar · Trodelvy · UKONIQ · ULTOMIRIS · VARUBI · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VPRIV · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XPOVIO · XT CDX · XTANDI · Xermelo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · Zevalin · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (85%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $9 per 100 Medicare services performed
Geographic Context
Hematologys within 10 mi
40
Per 100K population
4.2
County median income
$70,293
Nearest hospital
MORTON PLANT HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Patel is a mixed practice specialist, with moderate Medicare volume, and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Patel experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Patel performed 79,050 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $14,614 from 99 companies across 698 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Patel's costs compare to other hematologys in Clearwater?
Dr. Patel's average Medicare payment per service is $3. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologys in Clearwater
Browse hematologys in Clearwater ranked by procedure volume and transparency data.
Highest volume
Top Hematologys in FL
Hematologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologys in FL
Which FL hematologys receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology